Samalin Investment Counsel, LLC Pfizer Inc Transaction History

Samalin Investment Counsel, LLC

$222 Million
Q3 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 24,813 shares of PFE stock, worth $636,453. This represents 0.32% of its overall portfolio holdings.

Number of Shares

24,813

Previous 20,282 22.34%

Holding current value

$636,453

Previous $567,000 26.63%

% of portfolio

0.32%

Previous 0.27%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $125,508 - $142,228	4,531 Added 22.34%	24,813 $718,000
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $25,891 - $30,340	1,025 Added 5.32%	20,282 $567,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $15,119 - $17,362	584 Added 3.13%	19,257 $534,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $192,342 - $249,832	7,361 Added 65.07%	18,673 $537,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $27,661 - $32,333	862 Added 8.25%	11,312 $375,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $1,336 - $1,546	37 Added 0.36%	10,450 $383,000
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $28,085 - $36,562	-713 Reduced 6.41%	10,413 $424,000
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $22,795 - $29,757	-546 Reduced 4.68%	11,126 $570,000
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $34,614 - $42,255	791 Added 7.27%	11,672 $511,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1,535 - $1,820	33 Added 0.3%	10,881 $571,000
Q1 2022 Oct 13, 2022	SELL	$45.75 - $56.69 $21,822 - $27,041	-477 Reduced 4.21%	10,848 $562,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $21,822 - $27,041	-477 Reduced 4.21%	10,848 $562 Million
Q4 2021 Oct 13, 2022	BUY	$41.32 - $61.25 $14,007 - $20,763	339 Added 3.09%	11,325 $669,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $14,007 - $20,763	339 Added 3.09%	11,325 $669 Million
Q3 2021 Oct 13, 2022	BUY	$39.25 - $50.42 $15,111 - $19,411	385 Added 3.63%	10,986 $472,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $15,111 - $19,411	385 Added 3.63%	10,986 $472 Million
Q2 2021 Oct 13, 2022	BUY	$35.91 - $40.68 $16,841 - $19,078	469 Added 4.63%	10,601 $415,000
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $1,544 - $1,749	43 Added 0.41%	10,601 $415,000
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $14,266 - $16,090	426 Added 4.2%	10,558 $382,000
Q4 2020 Oct 13, 2022	BUY	$33.47 - $42.56 $16,668 - $21,194	498 Added 5.17%	10,132 $373,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $16,668 - $21,194	498 Added 5.17%	10,132 $373 Million
Q3 2020 Oct 13, 2022	SELL	$31.75 - $37.25 $39,592 - $46,450	-1,247 Reduced 11.46%	9,634 $354,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $1,206 - $1,415	38 Added 0.4%	9,634 $335,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $67,438 - $81,813	2,239 Added 30.43%	9,596 $313,000
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $243 - $347	-9 Reduced 0.12%	7,357 $240,000
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $242,488 - $275,193	7,366 New	7,366 $288,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Pfizer Inc Transaction History